SCHEMBL31729273

SCHEMBL31729273

Cn1cc(C2CCC(=O)NC2=O)c2ccc(C3CCN(C(=O)OC(C)(C)C)CC3)cc21

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 11/20 0.54
▸ CRBN Q96SW2 11/20 0.54
▸ SCN9A Q15858 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ PRKCB P05771 1/20 0.42
▸ PRKCA P17252 1/20 0.42
▸ PRKCH P24723 1/20 0.42
▸ PRKCE Q02156 1/20 0.42
▸ PRKCD Q05655 1/20 0.42
▸ NAMPT P43490 1/20 0.40
▸ TLR9 Q9NR96 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ P2RY14 Q15391 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31520618 0.86 DDB1 (0.52) DDB1CRBNSCN9AKDM4EMAPT
SCHEMBL31451208 0.86 DDB1 (0.54) DDB1CRBNSCN9AMAPTPRKCG
SCHEMBL31620092 0.85 DDB1 (0.49) DDB1CRBNSCN9AKDM4EMAPT
SCHEMBL31729374 0.84 DDB1 (0.43) DDB1CRBN
SCHEMBL23540247 0.83 DDB1 (0.75) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL30026749 0.83 DDB1 (0.75) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL24319591 0.83 DDB1 (0.58) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL31729305 0.82 DDB1 (0.54) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL23301622 0.82 CRBN (0.67) DDB1CRBNKDM4EMAPTTHRB
SCHEMBL25187964 0.82 CRBN (0.67) DDB1CRBNKDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235298-A1 BIFUNCTIONAL COMPOUNDS CONTAINING THIAZOLYL DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-11-13 — — WO disclosed
Send feedback